PRA Health Sciences Inc. gave three of its top executives stock options totaling 210,000 shares, according to a filing Tuesday with the Securities and Exchange Commission.
Chief Executive Officer Colin Shannon received 130,000 shares, and Chief Financial Officer Linda Baddour received 30,000 shares. David W. Dockhorn, executive vice president and corporate compliance officer, received 50,000 shares.
The stock options were priced at $75.81, which was the closing price of the company’s stock the day prior to the grant date, and they will expire in 10 years on Aug. 29, 2027.
Shannon has been the chief executive officer at the Raleigh-based health care company since Jan. 1, 2010, and has been its president since May 2007. Shannon also served as chief operating officer of PRA International.
Last month, Shannon profited $27.6 million by exercising options and selling the stock at the market price.
PRA Health Sciences is one of the world’s largest contract research organizations that helps bring to market different health science products including treatment therapies and pharmaceutical drugs. The company works heavily in the fields of neurology, psychiatry, oncology, hematology and infectious diseases.
PharmaTimes has named PRA Health Sciences International Clinical Company of the Year since 2014.
The company’s stock closed at $77.81, up $2, or 2.6 percent, from the company announcement.
The complete 8-K form can be found here.